Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone

Author： Takeiri Masatoshi   Tachibana Miyuki   Kaneda Ayumi   Ito Ayumi   Ishikawa Yuichi   Nishiyama Shigeru   Goto Ryoichi   Yamashita Kenichiro   Shibasaki Susumu   Hirokata Gentaro   Ozaki Michitaka   Todo Satoru   Umezawa Kazuo  

Publisher： Springer Publishing Company

ISSN： 1023-3830

Source： Inflammation Research, Vol.60, Iss.9, 2011-09, pp. : 879-888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

DTCM-Glutarimide Hinders Growth of Childhood Leukemia Cells but Fails to Improve the Efficacy of Commonly Used Chemotherapeutic Agents

By  

Current Bioactive Compounds, Vol. 13, Iss. 1, 2016-12 ,pp. : 41-46

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata L.

By Soares M.B.P.   Bellintani M.C.   Ribeiro I.M.   Tomassini T.C.B.   Ribeiro dos Santos R.  

European Journal of Pharmacology, Vol. 459, Iss. 1, 2003-01 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection

By Molina J.F.   Poli S.   Vos I.H.C.   Joles J.A.   Schurink M.   Weckbecker G.   Stojanovic T.   Rabelink T.J.   Grone H.-J.  

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy

By Ghosh P.   Shimmon S.   Whitehouse M.  

Inflammopharmacology, Vol. 14, Iss. 3-4, 2006-08 ,pp. : 161-168

Springer Publishing Company

Access to resources Recommend Favorite

Novel piperazine and piperidine compounds for schizophrenia

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 737-740

Informa Healthcare

Access to resources Recommend Favorite